Adverse drug reactions in children reported by means of the yellow card in Spain

Journal of Clinical Epidemiology

Volumn 53, Issue 10, 2000, Pages 1076-1080

  Morales Olivas, F J ^a,b   Martinez Mir I ^b,c   Ferrer, J M ^a   Rubio, E ^a,b,c   Palop, V ^a  

^a Centro de Farmacovigilancia   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Adverse drug reactions; Pediatric patients; Pharmacoepidemiology; Pharmacovigilance; Spontaneous reporting

Indexed keywords

ACETYLSALICYLIC ACID; AMBROXOL; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BETAMETHASONE; BROMHEXINE; CARBAMAZEPINE; COTRIMOXAZOLE; DIGESTIVE TRACT AGENT; DIMEMORFAN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPROPHYLLINE; ERYTHROMYCIN; FENTANYL; GENTAMICIN; MEASLES MUMPS RUBELLA VACCINE; MIOKAMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; POLIOMYELITIS VACCINE; RESPIRATORY TRACT AGENT; TETANUS ANTIBODY; UNINDEXED DRUG; VACCINE;

ADOLESCENT; ANAPHYLACTIC SHOCK; ARTICLE; CARDIOTOXICITY; CHILD; CHILD HEALTH CARE; DIARRHEA; DRUG SURVEILLANCE PROGRAM; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROTOXICITY; PHARMACOEPIDEMIOLOGY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PRURITUS; RASH; REYE SYNDROME; SEX DIFFERENCE; SKIN TOXICITY; SPAIN; STEVENS JOHNSON SYNDROME; URTICARIA;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; INFANT; MALE; PHARMACEUTICAL PREPARATIONS; PHARMACOEPIDEMIOLOGY; SPAIN;

EID: 0343278970     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(00)00190-6     Document Type: Article

References (32)

1. Morales-Olivas F.J., Carpi Lobatón R. Publicaciones sobre reacciones adversas a medicamentos en revistas pediátricas españolas entre 1980 y 1984. An Esp Pediatr. 30:1989;116-118.
2. Bonati M. Epidemiologic evaluation of drug use in children. J Clin Pharmacol. 34:1994;300-305.
3. Kramer M.S., Hutchinson T.A., Flegel K.M., Naimark L., Contardi R., Leduc D.G. Adverse drug reactions in general pediatric outpatients. J Pediatr. 106:1985;305-310.
4. Sanz E., Boada J. Adverse drug reactions in paediatric outpatients. Int J Clin Pharmacol Res. 7:1987;169-172.
5. Woods C.G., Rylance M.E., Cullen R.E., Rylance G.W. Adverse reactions to drugs in children. Br Med J. 294:1987;869-870.
6. Mitchell A.A., Lacouture P.G., Sheehan J.E., Kauffman R.E., Shapiro S. Adverse drug reactions in children leading to hospital admission. Pediatrics. 82:1988;24-29.
7. Cirko-Begovic A., Vrhovac B., Bakran I. Intensive monitoring of adverse drug reactions in infants and preschool children. Eur J Clin Pharmacol. 36:1989;63-65.
8. Vazquez de la Villa A., Luna del Castillo J.D., Galdo Muñoz G., Puche Cafias E. Reacciones adversas causadas por medicamentos en Pediatría. An Esp Pediatr. 31:1989;49-53.
9. Meyboom R.H.B. Adverse reactions to drugs in children, experiences with spontaneous monitoring in the Netherlands. Bratisl Lek Listy. 92:1991;554-559.
10. Morales-Olivas F.J., Ferrer Casanova J.M., Palop Larrea V., Rubio Gomis E., Carpi Lobatón R. Reacciones adversas a medicamentos en niños. Seis años de experiencia del programa de notificación voluntaria en la Comunidad Valenciana. An Esp Pediatr. 42:1995;275-279.
11. Martínez-Mir I., García-López M., Palop V., Ferrer J.M., Estañ L., Rubio E., Morales-Olivas F.J. A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol. 42:1996;319-324.
12. Leary P.M. Adverse reactions in children. Special considerations in prevention and management. Drug Safety. 6:1991;171-182.
13. McQueen E.G. Pharmacological basis of adverse drug reactions. Speight T.M. Avery's Drug Treatment. 3rd edition:1987;223-254 Adis Press, Auckland, NZ.
14. Olive G. Pharmacovigilance chez l'enfant. Therapie. 44:1989;141-144.
15. Laporte J.R., Capellá D. El desarrollo de la farmacovigilancia en España. Inf Ter SS. 9:1985;129-135.
16. Capellá D., Avila P., Cabeza L., Moreno V., Vidal X., Laporte J.R. Cuatro años de experiencia en Farmacovigilancia. Med Clin (Barc). 91:1988;93-96.
17. Laporte J.R. Spain. Inmann W.H.W. Monitoring for Drug Safety. 2nd edition:1986;143-152 MTP Press, Lancaster, PA.
18. Morales-Olivas F.J., Ferrer J.M., Palop V., Rubio E. Reacciones adversas por fármacos inhibidores de la enzima conversiva de la angiotensina notificadas por medio de tarjeta amarilla. Med Clin (Barc). 103:1994;321-325.
19. Rawlins M.D. Spontaneous reporting of adverse drug reactions II. The Uses Br J Clin Pharmac. 26:1988;7-11.
20. Martínez-Mir I., Ferrer J.M., Palop V. Estañ L, Rubio E, Morales-Olivas FJ. Are the adverse drug reactions of amoxycillin and amoxycillin-clavulanic acid similar? Pharmacoepidemiol Drug Safety. 5:1996;247-254.
21. Meybroom R.H.B., Royer R.J. Causality classification at pharmacovigilance centers in the European Community. Pharmacoepidemiol Drugs Safety. 1:1992;87-89.
22. Mann R.D., Rawlins M.D., Fletcher P., Wood S.M. Age and the spontaneous reporting of adverse reactions in the United Kingdom. Pharmacoepidemiol Drug Safety. 1:1992;19-23.
23. Bern J.L., Breckenridge A.M., Mann R.D., Rawlins M.D. Review of yellow cards (1986). Report to the Committee on the Safety of Medicines Br J Clin Pharmacol. 26:1988;679-689.
24. Sanz E.J. Drug use in non-hospitalized children. Pharm Weekbl (Sci). 14:1992;1-8.
25. Smith M.B.H., Feldman W. Over-the-counter cold medications. a critical review of clinical trials between 1950 and 1991 JAMA. 269:1993;2258-2263.
26. Rawlins M.D. Spontaneous reporting of adverse drug reactions I. The Data Br J Clin Pharmac. 26:1988;1-6.
27. Anonymous Australian Adverse Drug Reactions Bulletin. 11:1992;14.
28. Roca I., Martínez J., Duran Bellido M., Suns I., Granell J.C., Iglesias Salvador D., Hidalgo Ibañez M.J., Juncosa Morros T., Latorre Otin C. Amoxicilina más ácido clavulánico en el tratamiento de las infecciones urinarias en pediatría. An Esp Pediatr. 32:1990;53-57.
29. Ibañez L., Laporte J.R., Camé X. Adverse drug reaction leading to hospital admission. Drug Safety. 6:1991;450-459.
30. Martínez-Mir I., García-López M., Palop V., Ferrer J.M., Rubio E., Morales-Olivas F.J. A prospective study of the adverse drug reactions in hospitalized children. Br J Clin Pharmacol. 47:1999;681-688.
31. Wessling A., Soderman P., Boethius G. Monitoring of drug prescriptions for children in the county of Jämtland and in Sweden as a whole in 1977-1987. Acta Pediatr Scand. 80:1991;944-952.
32. Tomson G. Pharmacoepidemiology and children. Bush P.J., Trakas D.J., Sanz E.J., Wirsing R.L., Vaskilampi T., Prout A. Children, Medicines, and Culture. 1996;375-383 Pharmaceutical Products Press, Binghamton, NY.